Trials / Completed
CompletedNCT00603707
Assessment of Whole Gut Transit Time Using the SmartPill Capsule
Assessment of Whole Gut Transit Time Using the SmartPill Capsule: a Multi-Center Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 178 (actual)
- Sponsor
- The SmartPill Corporation · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
Our null hypothesis states that the two techniques (Sitzmarks radioopaque markers and SmartPill) are equivalent and is demonstrated if the study population shows a correlation of 0.7 or higher.
Detailed description
The purpose of the study is to measure total gastrointestinal transit time using SmartPill GI Monitoring System with pH.p Capsule and compare the transit time determined by capsule transit to the conventional radioopaque marker technique. Both techniques are simultaneously applied in normal and constipated adult populations.
Conditions
Timeline
- Start date
- 2006-10-01
- Primary completion
- 2008-06-01
- Completion
- 2008-06-01
- First posted
- 2008-01-29
- Last updated
- 2008-08-29
Locations
8 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00603707. Inclusion in this directory is not an endorsement.